Srestha Finvest Share Price
0.26+0.01 (+4.00%)
-33.33% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | -13% |
| - | - | - | -2119% |
| - | -32% | -29% | -36% |
| -12% | -12% | -12% | -25% |
Peer Comparison
Symbol
BAJAJFINSV-A
AIIL-A
CHOLAHLDNG-A
TVSHLTD-A
CGCL-A
MAHSCOOTER-A
JMFINANCIL-A
JSWHL-A
RELIGARE-A
SYSTMTXC-T
SRESTHA-X
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,973 | ₹313684 Cr | 30.92 | 19.59 | 71.77 | ₹9801 Cr |
| 521.4 | ₹44100 Cr | 21.02 | 13.08 | 25.15 | ₹1932 Cr |
| 1,518.1 | ₹28227 Cr | 10.58 | 42.92 | 160.3 | ₹2441 Cr |
| 13,407.1 | ₹26595 Cr | 13.5 | 301.51 | 1,693.08 | ₹1696 Cr |
| 274.55 | ₹26147 Cr | 23.19 | 3.67 | 12.9 | ₹949 Cr |
| 13,578.05 | ₹15591 Cr | 55.98 | 2.9 | 243.71 | ₹311 Cr |
| 131 | ₹12871 Cr | 12.38 | 3.05 | 11.74 | ₹1202 Cr |
| 11,553 | ₹12790 Cr | 93.1 | 22.11 | 123.77 | ₹147 Cr |
| 257.1 | ₹8682 Cr | — | -0.28 | -1.02 | -₹34 Cr |
| 61.95 | ₹806 Cr | — | -0.36 | 0.33 | ₹14 Cr |
| 0.26 | ₹48 Cr | — | -0.16 | -0.19 | -₹8 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹94 L | ₹3 Cr | ₹40 Cr | ₹3 Cr |
| ₹1 Cr | ₹10,000 | ₹0 | ₹50 L | ₹0 | ₹15 L | ₹2 L | ₹0 | ₹7 L |
| ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹4 Cr | ₹40 Cr | ₹3 Cr |
| ₹40 Cr | ₹6 Cr | ₹66 L | ₹13 Cr | ₹73 L | ₹32 Cr | ₹27 Cr | ₹2 Cr | ₹3 Cr |
| -₹37 Cr | -₹5 Cr | ₹72 L | -₹11 Cr | ₹3 Cr | -₹31 Cr | -₹24 Cr | ₹38 Cr | ₹98 L |
| ₹0 | -₹77 L | ₹10,000 | ₹0 | ₹77 L | ₹76 L | ₹72 L | ₹1 Cr | ₹1 Cr |
| -₹37 Cr | -₹4 Cr | ₹57 L | -₹11 Cr | ₹2 Cr | -₹32 Cr | -₹25 Cr | ₹37 Cr | -₹46 L |
| -₹27 Cr | ₹47 L | ₹57 L | -₹11 Cr | ₹2 Cr | -₹27 Cr | -₹25 Cr | ₹31 Cr | -₹46 L |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Loans (Non - Current Assets)
Gross Block
Less Accumulated Depreciation
Net Block
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Cash and Bank
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 |
|---|---|
| — | — |
| ₹164 Cr | ₹116 Cr |
| ₹22 Cr | ₹0 |
| -₹17 Cr | ₹19 Cr |
| -₹17 Cr | ₹19 Cr |
| ₹169 Cr | ₹135 Cr |
| ₹10 L | ₹0 |
| -₹1 Cr | ₹5 Cr |
| -₹1 Cr | ₹5 Cr |
| — | — |
| ₹9 L | ₹1 Cr |
| ₹7 L | ₹40 L |
| ₹57 Cr | ₹50 Cr |
| ₹4 Cr | ₹2 Cr |
| ₹60 Cr | ₹53 Cr |
| ₹228 Cr | ₹193 Cr |
| ₹57 Cr | ₹50 Cr |
| — | — |
| ₹129 Cr | ₹112 Cr |
| ₹3 Cr | ₹3 Cr |
| ₹1 Cr | ₹65 L |
| ₹2 Cr | ₹2 Cr |
| ₹22 Cr | ₹9 Cr |
| ₹153 Cr | ₹124 Cr |
| — | — |
| ₹67 Cr | ₹59 Cr |
| ₹7 Cr | ₹10 Cr |
| ₹89 L | ₹76 L |
| ₹75 Cr | ₹69 Cr |
| ₹15 Cr | ₹16 Cr |
| ₹228 Cr | ₹193 Cr |
| ₹1 | ₹1 |
| ₹1 | ₹1 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 |
|---|---|
| -₹35 Cr | ₹2 Cr |
| ₹6 Cr | -₹63 L |
| -₹25 Cr | -₹15 Cr |
| -₹53 Cr | -₹14 Cr |
| -₹54 Cr | -₹14 Cr |
| -₹19 Cr | -₹27 Cr |
| ₹71 Cr | ₹50 Cr |
| -₹2 Cr | ₹9 Cr |
| ₹10 Cr | ₹1 Cr |
| ₹7 Cr | ₹10 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found